CACNB2 Antibody
CACNB2 Antibody
Product Specifications
Product Name Alternative
AW060387 antibody; Ca (V) beta 2 antibody; CAB2 antibody; CACB2_HUMAN antibody; CACNB2 antibody; CACNLB2 antibody; Calcium channel voltage dependent subunit beta 2 antibody; Calcium channel voltage-dependent subunit beta 2 antibody; Calcium channel; voltage dependent; beta 2 subunit antibody; CAVB2 antibody; Cavbeta2 antibody; Cchb2 antibody; FLJ23743 antibody; Lambert Eaton Myasthenic syndrome antigen antibody; Lambert Eaton myasthenic syndrome antigen B antibody; Lambert-Eaton myasthenic syndrome antigen B antibody; MGC129334 antibody; MGC129335 antibody; Myasthenic (Lambert Eaton) syndrome antigen B antibody; Myasthenic syndrome antigen B antibody; MYSB antibody; Voltage dependent L type calcium channel subunit beta 2 antibody; Voltage-dependent L-type calcium channel subunit beta-2 antibody
UniProt
Q08289
Reactivity
Human, Mouse, Rat
Immunogen
Synthetic peptide of Human CACNB2
Target
CACNB2
Clonality
Polyclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Purification
Antigen Affinity Purified
Dilution
ELISA:1:2000-1:5000, IHC-P:1:50-1:200
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, IHC
Host or Source
Rabbit
Preservative
-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036637-PE 200 µL
HMGB1, CT (HMGB1, HMG1, High mobility group protein B1, High mobility group protein 1) (PE) discontinued
Sign In for Pricing
View Details 
169916-01 50 mg
Acyclovir (2-Amino-1,9-dihydro-9- ((2-hydroxyethoxy) methyl) -6H-purin-6-one, Aciclovir) discontinued
Sign In for Pricing
View Details 169916-02 250 mg
Acyclovir (2-Amino-1,9-dihydro-9- ((2-hydroxyethoxy) methyl) -6H-purin-6-one, Aciclovir) discontinued
Sign In for Pricing
View Details 